Royal Bank of Canada’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.86M Sell
68,309
-85,502
-56% -$4.99M ﹤0.01% 2605
2025
Q4
$9.14M Sell
153,811
-270,107
-64% -$14.7M ﹤0.01% 2000
2025
Q3
$23M Buy
423,918
+153,673
+57% +$8.79M ﹤0.01% 1537
2025
Q2
$14.9M Buy
270,245
+129,299
+92% +$7.61M ﹤0.01% 1743
2025
Q1
$9.96M Buy
140,946
+5,262
+4% +$354K ﹤0.01% 1746
2024
Q4
$8.92M Buy
135,684
+70,303
+108% +$4.71M ﹤0.01% 1876
2024
Q3
$4.59M Sell
65,381
-72,462
-53% -$6.06M ﹤0.01% 2349
2024
Q2
$11.3M Sell
137,843
-5,518
-4% -$459K ﹤0.01% 1597
2024
Q1
$12.5M Sell
143,361
-18,060
-11% -$1.62M ﹤0.01% 1542
2023
Q4
$15.6M Buy
161,421
+2,430
+2% +$215K ﹤0.01% 1432
2023
Q3
$14.1M Sell
158,991
-31,238
-16% -$2.78M ﹤0.01% 1355
2023
Q2
$16.5M Sell
190,229
-25,117
-12% -$2.36M ﹤0.01% 1266
2023
Q1
$20.9M Buy
215,346
+37,035
+21% +$3.84M 0.01% 1106
2022
Q4
$18.5M Buy
178,311
+11,815
+7% +$1.11M 0.01% 1205
2022
Q3
$14.1M Buy
166,496
+10,654
+7% +$949K ﹤0.01% 1300
2022
Q2
$12.9M Buy
155,842
+2,744
+2% +$218K ﹤0.01% 1397
2022
Q1
$11.8M Buy
153,098
+35,791
+31% +$2.99M ﹤0.01% 1599
2021
Q4
$10.4M Buy
117,307
+1,662
+1% +$137K ﹤0.01% 1860
2021
Q3
$8.94M Sell
115,645
-30,102
-21% -$2.38M ﹤0.01% 1906
2021
Q2
$12.2M Buy
145,747
+44,622
+44% +$3.54M ﹤0.01% 1696
2021
Q1
$7.64M Buy
101,125
+14,044
+16% +$1.15M ﹤0.01% 1943
2020
Q4
$7.64M Sell
87,081
-16,202
-16% -$1.28M ﹤0.01% 1907
2020
Q3
$7.86M Sell
103,283
-17,128
-14% -$1.73M ﹤0.01% 1703
2020
Q2
$14.9M Buy
120,411
+62,058
+106% +$6.17M 0.01% 1206
2020
Q1
$4.93M Buy
58,353
+4,168
+8% +$359K ﹤0.01% 1817
2019
Q4
$4.58M Buy
54,185
+8,961
+20% +$677K ﹤0.01% 2220
2019
Q3
$3.05M Buy
45,224
+6,346
+16% +$489K ﹤0.01% 2420
2019
Q2
$3.33M Buy
38,878
+6,138
+19% +$525K ﹤0.01% 2369
2019
Q1
$2.91M Sell
32,740
-6,574
-17% -$609K ﹤0.01% 2410
2018
Q4
$3.35M Buy
39,314
+2,512
+7% +$239K ﹤0.01% 2276
2018
Q3
$3.57M Sell
36,802
-1,367
-4% -$136K ﹤0.01% 2382
2018
Q2
$3.6M Sell
38,169
-11,893
-24% -$1.04M ﹤0.01% 2264
2018
Q1
$4.06M Buy
50,062
+12,257
+32% +$1.05M ﹤0.01% 2158
2017
Q4
$3.37M Buy
37,805
+3,472
+10% +$302K ﹤0.01% 2331
2017
Q3
$3.19M Sell
34,333
-7,833
-19% -$692K ﹤0.01% 2309
2017
Q2
$3.83M Buy
42,166
+2,066
+5% +$188K ﹤0.01% 2134
2017
Q1
$3.52M Buy
40,100
+6,940
+21% +$617K ﹤0.01% 2155
2016
Q4
$2.75M Sell
33,160
-4,771
-13% -$410K ﹤0.01% 2341
2016
Q3
$3.51M Buy
37,931
+11,647
+44% +$1.1M ﹤0.01% 2145
2016
Q2
$2.04M Buy
26,284
+2,332
+10% +$198K ﹤0.01% 2528
2016
Q1
$1.98M Sell
23,952
-25,758
-52% -$2.1M ﹤0.01% 2468
2015
Q4
$5.21M Buy
49,710
+3,752
+8% +$392K ﹤0.01% 1840
2015
Q3
$4.84M Buy
45,958
+2,747
+6% +$367K ﹤0.01% 1605
2015
Q2
$5.91M Sell
43,211
-8,827
-17% -$1.09M ﹤0.01% 1505
2015
Q1
$6.49M Sell
52,038
-55,647
-52% -$5.9M ﹤0.01% 1442
2014
Q4
$9.73M Buy
107,685
+5,153
+5% +$429K 0.01% 1241
2014
Q3
$7.4M Sell
102,532
-9,683
-9% -$636K 0.01% 1383
2014
Q2
$6.98M Buy
112,215
+61,731
+122% +$3.73M 0.01% 1419
2014
Q1
$3.44M Buy
50,484
+6,536
+15% +$482K ﹤0.01% 1852
2013
Q4
$3.09M Sell
43,948
-189
-0.4% -$12.8K ﹤0.01% 1976
2013
Q3
$3.19M Buy
44,137
+26,074
+144% +$1.73M ﹤0.01% 1883
2013
Q2
$1.01M Buy
+18,063
New +$1.13M ﹤0.01% 2571

Other funds holding BMRN